Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

86 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Completed

A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma

NCT00668148

Conditions
Adipocytic Sarcoma, Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET), Leiomyosarcoma, +20 more
Locations
  • ImClone Investigational Site Aurora, Colorado, United States
  • ImClone Investigational Site Orlando, Florida, United States
  • ImClone Investigational Site Metairie, Louisiana, United States
  • ImClone Investigational Site Metairie, Louisiana, United States
View all 22 locations
View Trial Details
Completed

A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers

NCT02132468

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Markey Cancer Center, Clinical Research Office Lexington, Kentucky, United States
  • Montefiore The Bronx, New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

NCT01975116

Conditions
Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Astrocytoma, +28 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
View Trial Details
Completed

BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.

NCT01658436

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +6 more
Locations
  • Indiana University SC Indianapolis, Indiana, United States
  • Dana Farber Cancer Institute GastrointestionalCancer Clinic Boston, Massachusetts, United States
  • Montefiore Medical Center SC-2 The Bronx, New York, United States
  • Ohio State Comprehensive Cancer Center/James Cancer Hospital SC Columbus, Ohio, United States
View all 17 locations
View Trial Details

Related conditions